Obesity and Risk of Colorectal Cancer: a Systematic Review of Prospective Studies

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Jan 26

PMID 23349764

Citations 294

Authors

Yanlei Ma

Yongzhi Yang

Feng Wang

Peng Zhang

Chenzhang Shi

Yang Zou

Huanlong Qin

Affiliations

Soon will be listed here.

Abstract

Background: Mounting evidence indicates that obesity may be associated with the risk of colorectal cancer (CRC). To conduct a systematic review of prospective studies assessing the association of obesity with the risk of CRC using meta-analysis.

Methodology/principal Findings: Relevant studies were identified by a search of MEDLINE and EMBASE databases before January 2012, with no restrictions. We also reviewed reference lists from retrieved articles. We included prospective studies that reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the association between general obesity [measured using body mass index (BMI)] or central obesity [measured using waist circumference (WC)] and the risk of colorectal, colon, or rectal cancer. Approximately 9, 000, 000 participants from several countries were included in this analysis. 41 studies on general obesity and 13 studies on central obesity were included in the meta-analysis. The pooled RRs of CRC for the obese vs. normal category of BMI were 1.334 (95% CI, 1.253-1.420), and the highest vs. lowest category of WC were 1.455 (95% CI, 1.327-1.596). There was heterogeneity among studies of BMI (P<0.001) but not among studies of WC (P=0.323).

Conclusions: Both of general and central obesity were positively associated with the risk of CRC in this meta-analysis.

Citing Articles

Colorectal Cancer and Central Obesity.

Safizadeh F, Mandic M, Hoffmeister M, Brenner H JAMA Netw Open. 2025; 8(1):e2454753.

PMID: 39820694 PMC: 11739990. DOI: 10.1001/jamanetworkopen.2024.54753.

Obesity, Physical Activity, and Cancer Incidence in Two Geographically Distinct Populations; The Gulf Cooperation Council Countries and the United Kingdom-A Systematic Review and Meta-Analysis.

Gaskell C, Lutimba S, Bendriss G, Aleem E Cancers (Basel). 2025; 16(24.

PMID: 39766104 PMC: 11674634. DOI: 10.3390/cancers16244205.

Evaluation of preoperative visceral fat area / psoas muscle area ratio and prognosis in patients with colorectal cancer.

Hosoi N, Shiraishi T, Okada T, Osone K, Yokobori T, Sakai M Ann Gastroenterol Surg. 2025; 9(1):119-127.

PMID: 39759994 PMC: 11693571. DOI: 10.1002/ags3.12845.

Age and sex differences in the relationship of body weight changes with colon cancer risks: A nationwide cohort study.

Kim J, Ko Y, Kim H, Park S Sci Rep. 2025; 15(1):678.

PMID: 39753614 PMC: 11698967. DOI: 10.1038/s41598-024-74916-1.

The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study.

Anson M, Poon J, Henney A, Riley D, Ibarbaru G, Sieberhagen C BMC Med. 2024; 22(1):574.

PMID: 39627877 PMC: 11613771. DOI: 10.1186/s12916-024-03802-4.

References

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H . Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst. 2000; 92(19):1592-600. DOI: 10.1093/jnci/92.19.1592. View

Renehan A, Roberts D, Dive C . Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008; 114(1):71-83. DOI: 10.1080/13813450801954303. View

Giovannucci E, Ascherio A, Rimm E, Colditz G, Stampfer M, Willett W . Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995; 122(5):327-34. DOI: 10.7326/0003-4819-122-5-199503010-00002. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Renehan A, Zwahlen M, Minder C, ODwyer S, Shalet S, Egger M . Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004; 363(9418):1346-53. DOI: 10.1016/S0140-6736(04)16044-3. View

Bostick R, Potter J, Kushi L, Sellers T, Steinmetz K, McKenzie D . Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control. 1994; 5(1):38-52. DOI: 10.1007/BF01830725. View

Chung Y, Han D, Park Y, Son B, Paik C, Lee H . Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis. 2006; 38(9):668-72. DOI: 10.1016/j.dld.2006.05.014. View

Thygesen L, Gronbaek M, Johansen C, Fuchs C, Willett W, Giovannucci E . Prospective weight change and colon cancer risk in male US health professionals. Int J Cancer. 2008; 123(5):1160-5. PMC: 3965300. DOI: 10.1002/ijc.23612. View

10.

Wang Y, Jacobs E, Patel A, Rodriguez C, McCullough M, Thun M . A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence. Cancer Causes Control. 2008; 19(7):783-92. DOI: 10.1007/s10552-008-9141-x. View

11.

Park J, Mitrou P, Keogh R, Luben R, Wareham N, Khaw K . Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study. Int J Obes (Lond). 2011; 36(1):107-18. DOI: 10.1038/ijo.2011.61. View

12.

Larsson S, Rutegard J, Bergkvist L, Wolk A . Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer. 2006; 42(15):2590-7. DOI: 10.1016/j.ejca.2006.04.015. View

13.

Samanic C, Chow W, Gridley G, Jarvholm B, Fraumeni Jr J . Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006; 17(7):901-9. DOI: 10.1007/s10552-006-0023-9. View

14.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H . Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009; 30(2):113-25. DOI: 10.1111/j.1365-2036.2009.04022.x. View

15.

Stattin P, Palmqvist R, Soderberg S, Biessy C, Ardnor B, Hallmans G . Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep. 2003; 10(6):2015-21. View

16.

Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R . Obesity and colon cancer: does leptin provide a link?. Int J Cancer. 2004; 109(1):149-52. DOI: 10.1002/ijc.11668. View

17.

Odegaard A, Koh W, Yu M, Yuan J . Body mass index and risk of colorectal cancer in Chinese Singaporeans: the Singapore Chinese Health Study. Cancer. 2011; 117(16):3841-9. PMC: 3151024. DOI: 10.1002/cncr.25936. View

18.

Wei E, Giovannucci E, Wu K, Rosner B, Fuchs C, Willett W . Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2003; 108(3):433-42. PMC: 2903217. DOI: 10.1002/ijc.11540. View

19.

Renehan A, Painter J, Atkin W, Potten C, Shalet S, ODwyer S . High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg. 2001; 88(1):107-13. DOI: 10.1046/j.1365-2168.2001.01645.x. View

20.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View